Synopsis
Synopsis
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5'-monophosphate, Riboflavin
2. 5'-phosphate, Riboflavin
3. Flavin Mononucleotide
4. Flavin Mononucleotide Disodium Salt
5. Flavin Mononucleotide Monosodium Salt
6. Flavin Mononucleotide Monosodium Salt, Dihydrate
7. Flavin Mononucleotide Sodium Salt
8. Fmn
9. Mononucleotide, Flavin
10. Mononucleotide, Riboflavin
11. Phosphate, Sodium Riboflavin
12. Riboflavin 5' Monophosphate
13. Riboflavin 5' Phosphate
14. Riboflavin 5'-monophosphate
15. Riboflavin 5'-phosphate
16. Riboflavin Mononucleotide
17. Riboflavin Phosphate, Sodium
18. Sodium Riboflavin Phosphate
1. 130-40-5
2. Riboflavin 5'-phosphate Sodium
3. Riboflavin-5'-phosphate Sodium
4. Photrexa
5. Riboflavin Phosphate Sodium
6. Fmn-na
7. Flavin Mononucleotide
8. Riboflavin 5-phosphate Sodium
9. Riboflavin (phosphate Sodium)
10. Vitamin B2 Phosphate Sodium Salt
11. Riboflavin 5'-monophosphate Sodium Salt
12. Riboflavin 5'-phosphate Sodium Anhydrous
13. Sodium Riboflavin 5'-phosphate
14. Lactoflavin Phosphate Sodium Salt
15. 957e53wv42
16. Riboflavin 5'-(dihydrogen Phosphate), Sodium Salt (1:1)
17. Photrexa Viscous In Dextran 20%
18. Riboflavin Sodium Phosphate [jan]
19. Riboflavin 5'-(dihydrogen Phosphate), Monosodium Salt
20. Sodium Riboflavin Phosphate
21. Riboflavina 5 Fosfato De Sodio
22. Unii-957e53wv42
23. Infuvite (tn)
24. Einecs 204-988-6
25. Einecs 244-868-0
26. Photrexa Viscous
27. Riboflavin 5'-(sodium Hydrogen Phosphate)
28. Nsc-759230
29. Schembl26122
30. Riboflavin 5'-(dihydrogen Phosphate), Sodium Salt
31. Ins No.101(ii)
32. Riboflavine-5'-phosphate Sodium
33. Chebi:32098
34. Ins-101(ii)
35. Riboflavin Sodium Phosphate,(s)
36. Dtxsid80889330
37. Flavin Mononucleotide Sodium Salt
38. Hy-b0964
39. Riboflavin Sodium Phosphate (jp17)
40. E-101(ii)
41. Flavin Mononucleotide Monosodium Salt
42. Mfcd00065362
43. Ccg-269524
44. Cs-4449
45. Nsc 759230
46. Riboflavin Monophosphate Monosodium Salt
47. 22251-85-0
48. E106
49. Sodium Riboflavin Phosphate [inci]
50. Riboflavin Sodium Phosphate [mart.]
51. Riboflavin Sodium Phosphate Anhydrous
52. R0023
53. R0249
54. Riboflavin Sodium Phosphate [who-dd]
55. D01622
56. A806082
57. Flavin Mononucleotide Monosodium Salt [mi]
58. Riboflavin Sodium Phosphate [ep Monograph]
59. W-108348
60. Q27271760
61. Sodium (2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2h)-yl)-2,3,4-trihydroxypentyl Hydrogen Phosphate
62. Sodium (2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2h)-yl)-2,3,4-trihydroxypentyl Hydrogenphosphate
63. Sodium [5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentyl] Hydrogen Phosphate Dihydrate;riboflavin Phosphate Sodium
64. Sodium;[(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] Hydrogen Phosphate
| Molecular Weight | 478.3 g/mol |
|---|---|
| Molecular Formula | C17H20N4NaO9P |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | 478.08655951 g/mol |
| Monoisotopic Mass | 478.08655951 g/mol |
| Topological Polar Surface Area | 204 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 856 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Vitamin B Complex
A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)
API SUPPLIERS
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27005
Submission : 2013-03-02
Status : Active
Type : II
Registration Number : 306MF10052
Registrant's Address : 207/208, Udyog Bhavan, Sonawala Road, Goregaon East, Mumbai, India
Initial Date of Registration : 2024-04-03
Latest Date of Registration :
Date of Issue : 2022-06-29
Valid Till : 2025-07-02
Written Confirmation Number : WC-0218
Address of the Firm :
NDC Package Code : 61281-7000
Start Marketing Date : 2013-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29923
Submission : 2015-10-08
Status : Active
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41244
Submission : 2025-03-13
Status : Active
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-07-11
Pay. Date : 2017-01-10
DMF Number : 30831
Submission : 2016-09-07
Status : Active
Type : II
Certificate Number : CEP 1999-123 - Rev 02
Issue Date : 2023-10-04
Type : Chemical
Substance Number : 786
Status : Valid
Registration Number : 219MF10120
Registrant's Address : Wurmisweg 576, CH-4303, Kaiseraugst, Switzerland
Initial Date of Registration : 2007-03-23
Latest Date of Registration :
NDC Package Code : 63238-3200
Start Marketing Date : 2024-02-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27188
Submission : 2013-09-13
Status : Active
Type : II
NDC Package Code : 64181-0087
Start Marketing Date : 2004-01-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.16kg/.16kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-11-15
Pay. Date : 2024-03-29
DMF Number : 39297
Submission : 2023-12-21
Status : Active
Type : II
Certificate Number : CEP 2023-436 - Rev 00
Issue Date : 2024-12-17
Type : Chemical
Substance Number : 786
Status : Valid
Registration Number : 217MF11123
Registrant's Address : 1 boulevard d'Alsace, F-68128 Village-Neuf, France
Initial Date of Registration : 2005-12-05
Latest Date of Registration :
NDC Package Code : 63238-3200
Start Marketing Date : 2017-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6582
Submission : 1986-09-08
Status : Inactive
Type : II
Date of Issue : 2020-12-15
Valid Till : 2023-11-12
Written Confirmation Number : WC-0415
Address of the Firm :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - FOR SOLUTION;INTRAVENOUS - 80MG/VIAL...DOSAGE - FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
USFDA APPLICATION NUMBER - 18920
DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/...DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
USFDA APPLICATION NUMBER - 21163
DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/...DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
USFDA APPLICATION NUMBER - 21163
DOSAGE - INJECTABLE;INTRAVENOUS - 200MG/VIAL;...DOSAGE - INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
USFDA APPLICATION NUMBER - 21625
DOSAGE - INJECTABLE;INJECTION - 20MG/ML;0.006...DOSAGE - INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML
USFDA APPLICATION NUMBER - 8809
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Parenteral
Solubilizers
Taste Masking
Film Formers & Plasticizers
Topical
Chewable & Orodispersible Aids
Direct Compression
Thickeners and Stabilizers
Coating Systems & Additives
Empty Capsules
Disintegrants & Superdisintegrants
Co-Processed Excipients
Emulsifying Agents
Surfactant & Foaming Agents
Granulation
Coloring Agents
Soft Gelatin
API Stability Enhancers
Rheology Modifiers
Controlled & Modified Release
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
86
PharmaCompass offers a list of Riboflavin Sodium Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Riboflavin Sodium Phosphate manufacturer or Riboflavin Sodium Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Riboflavin Sodium Phosphate manufacturer or Riboflavin Sodium Phosphate supplier.
PharmaCompass also assists you with knowing the Riboflavin Sodium Phosphate API Price utilized in the formulation of products. Riboflavin Sodium Phosphate API Price is not always fixed or binding as the Riboflavin Sodium Phosphate Price is obtained through a variety of data sources. The Riboflavin Sodium Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Riboflavin 5 Phosphate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Riboflavin 5 Phosphate Sodium, including repackagers and relabelers. The FDA regulates Riboflavin 5 Phosphate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Riboflavin 5 Phosphate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Riboflavin 5 Phosphate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Riboflavin 5 Phosphate Sodium supplier is an individual or a company that provides Riboflavin 5 Phosphate Sodium active pharmaceutical ingredient (API) or Riboflavin 5 Phosphate Sodium finished formulations upon request. The Riboflavin 5 Phosphate Sodium suppliers may include Riboflavin 5 Phosphate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Riboflavin 5 Phosphate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Riboflavin 5 Phosphate Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Riboflavin 5 Phosphate Sodium active pharmaceutical ingredient (API) in detail. Different forms of Riboflavin 5 Phosphate Sodium DMFs exist exist since differing nations have different regulations, such as Riboflavin 5 Phosphate Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Riboflavin 5 Phosphate Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Riboflavin 5 Phosphate Sodium USDMF includes data on Riboflavin 5 Phosphate Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Riboflavin 5 Phosphate Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Riboflavin 5 Phosphate Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Riboflavin 5 Phosphate Sodium Drug Master File in Japan (Riboflavin 5 Phosphate Sodium JDMF) empowers Riboflavin 5 Phosphate Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Riboflavin 5 Phosphate Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Riboflavin 5 Phosphate Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Riboflavin 5 Phosphate Sodium suppliers with JDMF on PharmaCompass.
A Riboflavin 5 Phosphate Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Riboflavin 5 Phosphate Sodium Certificate of Suitability (COS). The purpose of a Riboflavin 5 Phosphate Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Riboflavin 5 Phosphate Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Riboflavin 5 Phosphate Sodium to their clients by showing that a Riboflavin 5 Phosphate Sodium CEP has been issued for it. The manufacturer submits a Riboflavin 5 Phosphate Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Riboflavin 5 Phosphate Sodium CEP holder for the record. Additionally, the data presented in the Riboflavin 5 Phosphate Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Riboflavin 5 Phosphate Sodium DMF.
A Riboflavin 5 Phosphate Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Riboflavin 5 Phosphate Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Riboflavin 5 Phosphate Sodium suppliers with CEP (COS) on PharmaCompass.
A Riboflavin 5 Phosphate Sodium written confirmation (Riboflavin 5 Phosphate Sodium WC) is an official document issued by a regulatory agency to a Riboflavin 5 Phosphate Sodium manufacturer, verifying that the manufacturing facility of a Riboflavin 5 Phosphate Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Riboflavin 5 Phosphate Sodium APIs or Riboflavin 5 Phosphate Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Riboflavin 5 Phosphate Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Riboflavin 5 Phosphate Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Riboflavin 5 Phosphate Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Riboflavin 5 Phosphate Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Riboflavin 5 Phosphate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Riboflavin 5 Phosphate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Riboflavin 5 Phosphate Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Riboflavin 5 Phosphate Sodium suppliers with NDC on PharmaCompass.
Riboflavin 5 Phosphate Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Riboflavin 5 Phosphate Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Riboflavin 5 Phosphate Sodium GMP manufacturer or Riboflavin 5 Phosphate Sodium GMP API supplier for your needs.
A Riboflavin 5 Phosphate Sodium CoA (Certificate of Analysis) is a formal document that attests to Riboflavin 5 Phosphate Sodium's compliance with Riboflavin 5 Phosphate Sodium specifications and serves as a tool for batch-level quality control.
Riboflavin 5 Phosphate Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Riboflavin 5 Phosphate Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Riboflavin 5 Phosphate Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Riboflavin 5 Phosphate Sodium EP), Riboflavin 5 Phosphate Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Riboflavin 5 Phosphate Sodium USP).
